Related content

The Cannabinoid Receptor Agonist WIN 55,212-2 Reduces D 2 , but Not D 1 , Dopamine Receptor-Mediated Alleviation of Akinesia in the Reserpine-Treated Rat Model of Parkinson's Disease

By Maneuf Y.P.   Crossman A.R.   Brotchie J.M.  

Experimental Neurology, Vol. 148, Iss. 1, 1997-11 ,pp. : 265-270

Elsevier

Access to resources Recommend Favorite

Cyclosporin A Attenuates the Decrease in Tyrosine Hydroxylase Immunoreactivity in Nigrostriatal Dopaminergic Neurons and in Striatal Dopamine Content in Rats with Intrastriatal Injection of 6-Hydroxydopamine

By Matsuura K.   Makino H.   Ogawa N.  

Experimental Neurology, Vol. 146, Iss. 2, 1997-08 ,pp. : 526-535

Elsevier

Access to resources Recommend Favorite

Sarizotan, a serotonin 5-HT_1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile

By Bartoszyk G. D.   van Amsterdam C.   Greiner H. E.   Rautenberg W.   Russ H.   Seyfried C. A.  

Journal of Neural Transmission, Vol. 111, Iss. 2, 2004-02 ,pp. : 113-126

Springer Publishing Company

Access to resources Recommend Favorite

Dopamine D1 Receptor Associations within and between Dopaminergic Pathways in Younger and Elderly Adults: Links to Cognitive Performance

By Rieckmann Anna   Karlsson Sari   Karlsson Per   Brehmer Yvonne   Fischer Hkan   Farde Lars   Nyberg Lars   Bckman Lars  

Cerebral Cortex, Vol. 21, Iss. 9, 2011-09 ,pp. : 2023-2032

Oxford University Press

Access to resources Recommend Favorite

The dopamine receptor agonist pergolide enhances cortico-cortical inhibition in normal subjects: a transcranial magnetic stimulation study

By Ziemann U.   Bruns D.   Paulus W.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 109-109

Elsevier

Access to resources Recommend Favorite